Abstract:Abstract Investigating the role of cranial bone marrow mesenchymal stem cells (cBMMSC) based on nanosilver hydrogel nerve conduits in the repair of spinal cord injury. Thirty adult Wistar rats, male and female, with body mass of 210‐240 g, were selected as experimental animals and divided into control group and experimental group, 15 rats each, by random number table method. The experimental group was treated with spinal cord injury and localized transplantation of cBMMSC‐containing nanosilver hydrogel nerve conduits, while the control group was treated with spinal cord injury and localized transplantation of cBMMSC‐free nanosilver hydrogel nerve conduits. Four weeks after transplantation, the expression of neuron‐specific enolase (NSE) in rat anti‐human nuclear monoclonal antibody (MAB1281)‐positive cells was detected by immunostaining in spinal cord tissue sections of the two groups to assess the differentiation of cBMMSC to neuron‐like cells in the nerve conduits after transplantation; the number of BrdU‐positive cells was detected to assess the neuronal regeneration of the localized spinal cord injury of the two groups; and the length of axons was observed with laser Confocal photography was used to observe the length of axons; HE staining was used to observe the scarring and cavities in the spinal cord sections of the two groups; immunofluorescence was used to detect neuron‐like markers (Nestin, NSE, NF200, GFAP) in the two groups, and the OD values were determined by the Image Processing and Analysis System (IPAAS); and Western blot was used to detect the neurotransmitters of motor fibres, acetylcholinesterase (ChAT), sensory fibres, and sensory fibres, as well as the neurotransmission of motor fibres, acetylcholine production‐limiting enzyme (ChAT) and sensory fibre neurotransmitter glutamate synthase (GOGAT); motor function was assessed by BBB score; somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) were detected by body surface electrode assay in the two groups, and the neurophysiological recovery effect was evaluated. Four weeks after transplantation, the NSE content of MAB1281‐positive cells in the experimental group was significantly higher than that of the control group; the number of BrdU‐positive cells and axon length were significantly greater than that of the control group ( p < 0.05); the scarring and cavitation of spinal cord slices were significantly lighter than that of the control group; the expression levels of Nestin, NSE, NF200, GFAP, ChAT, GOGAT, and BBB scores were significantly higher than that of the control group ( p < 0.05); SEP and MEP latency time were significantly shorter than that of the control group ( p < 0.05), and wave amplitude was significantly greater than that of the control group ( p < 0.05). The cBMMSC transplantation based on nanosilver hydrogel nerve conduit was effective in repairing spinal cord injury, promoting neuronal and axonal regeneration, and restoring neuromotor and electrophysiological functions.

Transplantation of marrow stromal cells for the treatment of spinal cord injury:an ultrastructural observation

Transplantation Strategies for Spinal Cord Injury Based on Microenvironment Modulation

Marrow stromal cell transplantation enhances regeneration of neuronal axon after spinal cord transection

Mitochondrial Transfer from Bone Marrow Mesenchymal Stem Cells to Motor Neurons in Spinal Cord Injury Rats via Gap Junction.

Tissue-Engineered Regeneration of Completely Transected Spinal Cord Using Induced Neural Stem Cells and Gelatin-Electrospun Poly (Lactide-Co-Glycolide)/Polyethylene Glycol Scaffolds

The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model

Human umbilical cord-derived Schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury

Porous Microneedle Patch with Sustained Exosome Delivery Repairs Severe Spinal Cord Injury

Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord.

The Hetero-Transplantation of Human Bone Marrow Stromal Cells Carried by Hydrogel Unexpectedly Demonstrates a Significant Role in the Functional Recovery in the Injured Spinal Cord of Rats.

Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury

Experimental study of cBMMSC based on nanosilver hydrogel nerve conduit for repairing spinal cord injury

Improvement of neurological function in rats with spinal cord injury after the transplantation of neural stem cells directly differentiated from bone marrow mesenchymal stem cells

Transplantation of Pre‐Differentiated 3D Neural Spheroids in Decellularized Extracellular Matrix Microgels Promotes Neuronal Network Reconstruction and Functional Recovery after Severe Spinal Cord Contusion

Study on the adoption of Schwann cell phenotype by bone marrow stromal cells in vitro and in vivo

The treatment of spinal cord injury in rats using bone marrow-derived neural-like cells induced by cerebrospinal fluid

A combination of GDNF and hUCMSC transplantation loaded on SF/AGs composite scaffolds for spinal cord injury repair

Bone marrow stromal cell differentiation into schwann cells:in vitro and in vivo study

Umbilical Cord Mesenchymal Stem Cells Promoting Spinal Cord Injury Repair Visually Monitored by AIE‐Tat Nanoparticles

Tubular scaffold with microchannels and an H‐shaped lumen loaded with bone marrow stromal cells promotes neuroregeneration and inhibits apoptosis after spinal cord injury

Transplantation of Wnt5a-modified Bone Marrow Mesenchymal Stem Cells Promotes Recovery After Spinal Cord Injury via the PI3K/AKT Pathway